1.Heart Failure Statistics 2024 Update: A Report From the Korean Society of Heart Failure
Chan Joo LEE ; Hokyou LEE ; Minjae YOON ; Kyeong-Hyeon CHUN ; Min Gyu KONG ; Mi-Hyang JUNG ; In-Cheol KIM ; Jae Yeong CHO ; Jeehoon KANG ; Jin Joo PARK ; Hyeon Chang KIM ; Dong-Ju CHOI ; Jungkuk LEE ; Seok-Min KANG
International Journal of Heart Failure 2024;6(2):56-69
Background and Objectives:
The number of people with heart failure (HF) is increasing worldwide, and the social burden is increasing as HF has high mortality and morbidity. We aimed to provide updated trends on the epidemiology of HF in Korea to shape future social measures against HF.
Methods:
We used the National Health Information Database of the National Health Insurance Service to determine the prevalence, incidence, hospitalization rate, mortality rate, comorbidities, in-hospital mortality, and healthcare cost of patients with HF from 2002 to 2020 in Korea.
Results:
The prevalence of HF in the total Korean population rose from 0.77% in 2002 to 2.58% (1,326,886 people) in 2020. Although the age-standardized incidence of HF decreased over the past 18 years, the age-standardized prevalence increased. In 2020, the hospitalization rate for any cause in patients with HF was 1,166 per 100,000 persons, with a steady increase from 2002. In 2002, the HF mortality was 3.0 per 100,000 persons, which rose to 15.6 per 100,000 persons in 2020. While hospitalization rates and in-hospital mortality for patients with HF increased, the mortality rate for patients with HF did not (5.8% in 2020), and the one-year survival rate from the first diagnosis of HF improved. The total healthcare costs for patients with HF were approximately $2.4 billion in 2020, a 16-fold increase over the $0.15 billion in 2002.
Conclusions
The study’s results underscore the growing socioeconomic burden of HF in Korea, driven by an aging population and increasing HF prevalence.
2.Association Between Body Mass Index and Cognitive Function in Mild Cognitive Impairment Regardless of APOE ε4 Status
Ye Sol MUN ; Hee Kyung PARK ; Jihee KIM ; Jiyoung YEOM ; Geon Ha KIM ; Min Young CHUN ; Hye Ah LEE ; Soo Jin YOON ; Kyung Won PARK ; Eun-Joo KIM ; Bora YOON ; Jae-Won JANG ; Jin Yong HONG ; Seong Hye CHOI ; Jee Hyang JEONG
Dementia and Neurocognitive Disorders 2022;21(1):30-41
Background:
and Purpose: In this study we aimed to find the association between neuropsychological performance and body mass index (BMI) in patients with mild cognitive impairment (MCI). In addition, we investigated the effects of the apolipoprotein E (APOE) genotype in the relationship between the BMI and cognition in MCI.
Methods:
We enrolled a cohort of 3,038 subjects with MCI aged 65–90 from the Clinical Research Center for Dementia of South Korea and a dementia cohort of the Ewha Womans University Mokdong Hospital. MCI patients were classified into three subgroups according to the Asian standard of BMI. We compared cognitive performances between groups by one-way analysis of variance. To investigate the effects of the APOE genotype, we used multivariate linear regression models after adjusting for possible confounders.
Results:
Even though normal BMI groups were younger, had more females, and had less comorbidities, the higher BMI groups had better cognitive functions. Among subjects with APOE ε4 carriers, there was a positive relationship between the BMI and the memory task alone.
Conclusions
Our findings suggested that higher BMI in patients with MCI were associated with better cognitive performance. The effects of the APOE ε4 genotype in the associations between BMI and cognition were distinguishing. Therefore, according to physical status, APOE ε4 genotype-specific strategies in the assessments and treatments may be necessary in elderly patients with MCI.
3.The Value of Thermal Imaging for Knee Arthritis: A Single-Center Observational Study
Soo Min AHN ; Joo Hyang CHUN ; Seokchan HONG ; Chang‑Keun LEE ; Bin YOO ; Ji Seon OH ; Yong‑Gil KIM
Yonsei Medical Journal 2022;63(2):141-147
Purpose:
To compare (non-contact) thermal imaging with power Doppler (PD) for the evaluation of knee arthritis with joint effusion.
Materials and Methods:
We enrolled patients with knee arthritis who were scheduled to undergo an arthrocentesis of the knee from April to December 2020 at a single tertiary hospital. A thermography camera, FLIR ONE Pro, was used to obtain both thermographic and digital images on subjects. For each subject, thermography, ultrasonography, arthrocentesis, and blood tests were conducted at the same study visit. Thermal imaging findings and clinical characteristics were compared by dividing the subjects into PD-positive and PD-negative groups on ultrasound. The receiver operating characteristic (ROC) curve analysis was used to determine the accuracy of PD positivity.
Results:
A total of 30 knee arthritis patients were enrolled in this study. Knee temperature was significantly higher in PD-positive group compared to PD-negative group [maximum temperature (T max): 33.2°C vs. 30.5°C, p=0.025; minimum temperature (T min): 30.7°C vs. 27.0°C, p=0.015; average temperature (T ave): 32.1°C vs. 29.1°C, p=0.016]. Also, the joint fluid white blood cell count was considerably higher in PD-positive group than in PD-negative group (24556 cells/mm3 vs. 7840 cells/mm 3 , p=0.010). The area under the ROC curve of the point measurement of T max, T min, and T ave ranged between 0.764 and 0.790.
Conclusion
In this study, we found that high thermographic temperatures of the knee suggest a positive PD signal. Thus, thermography might be used as an adjuvant tool of PD for non-invasive evaluation of knee arthritis.
4.Control of type O foot-and-mouth disease by vaccination in Korea, 2014–2015
Jong Hyeon PARK ; Dongseob TARK ; Kwang Nyeong LEE ; Ji Eun CHUN ; Hyang Sim LEE ; Young Joon KO ; Soo Jeong KYE ; Yong Joo KIM ; Jae Ku OEM ; Soyoon RYOO ; Sung Bin LIM ; Seo Yong LEE ; Joo Hyung CHOI ; Mi Kyeong KO ; Su Hwa YOU ; Myoung Heon LEE ; Byounghan KIM
Journal of Veterinary Science 2018;19(2):271-279
On December 3, 2014, a type O foot-and-mouth disease (FMD) outbreak began in Korea. Although vaccinations were administered, FMD cases increased steadily for five months, and reached 185 cases by April 2015. Most of the affected animals were pigs, which are vulnerable to vaccination. The FMD virus belonged to the South-East Asia (SEA) topotype that had been observed three times in Korea between April 2010 and July 2014. However, the FMD virus isolated in December 2014 had a unique feature; that is, partial deletion of the 5′ non-coding region, a deletion not seen in previous SEA topotype isolates identified in Korea. We conclude that this outbreak included the introduction of a new FMD strain to Korea, and that Korea was now affected by genetically similar FMD virus strains that are related to those from neighboring countries.
Animals
;
Asia
;
Foot-and-Mouth Disease
;
Korea
;
Swine
;
Vaccination
5. Immune enhancement effect of an herb complex extract through the activation of natural killer cells and the regulation of cytokine levels in a cyclophosphamide-induced immunosuppression rat model
Sung Min WOO ; Woo Rin CHOI ; Hae Lim KIM ; Kyung Hyeon KIM ; Joo Won SUH ; Dooly JANG ; Chun Sik YI ; Joo Won SUH ; Jong Tae KIM ; Won Hee CHOI ; Seung Hee JANG ; Min Jeung KIM ; Ji Hyang WEE ; Yeon Ki KIM ; Bao LE ; Seung Hwan YANG
Asian Pacific Journal of Tropical Medicine 2018;11(12):653-658
Objective: To investigate the effects of a herb complex extract (HCE) prepared from Cornus officinalis Sieb. Et Zucc., Eriobotrya japonica Lindley, and olive leaves on immune response of mouse spleen NK cells in vitro and in vivo analysis. Methods: The activity of natural killer (NK) cells was measured in splenocytes and YAC-1 cells. Mice were immunosuppressed using cyclophosphamide (5 mg/kg body weight). Three different doses of HCE (200, 400, and 800 mg/kg body weight) and red ginseng extract (800 mg/kg body weight) which was used as standard immunomodulatory herb were administered orally for 4 weeks. The body weight, dietary, water intake, organs (liver, thymus, and spleen) weight, completed blood count, and cytokines (tumor necrosis factor alpha, interferon gamma, and interleukin-2) production was measured. Results: At the maximum concentration of HCE, the activity of NK cells was increased by 48.5%. HCE increased liver, spleen, and thymus weights without altering numbers of white blood cells, lymphocytes, and neutrophils in a cyclophosphamide-induced immunosuppression rat model. However, HCE recovered the inhibited cytokine expression; HCE (800 mg/kg) increased cytokines levels. The results indicate the immune enhancement potential of this HCE. Conclusion: The HCE enhances immunity by increasing NK cell activity, regulating cytokine levels, and maintaining spleen weight. Therefore, it may be used as a potential immunity enhancer.
6.Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational Study.
Sang Hoon PARK ; Choong Kee PARK ; Jin Woo LEE ; Young Seok KIM ; Sook Hyang JEONG ; Yun Soo KIM ; Ju Hyun KIM ; Seong Gyu HWANG ; Kyu Sung RIM ; Hyung Joon YIM ; Jae Youn CHEONG ; Sung Won CHO ; June Sung LEE ; Young Min PARK ; Jeong Won JANG ; Chun Kyon LEE ; Joo Hyun SHON ; Jin Mo YANG ; Young Soo JU
Gut and Liver 2012;6(1):98-106
BACKGROUND/AIMS: We aimed to evaluate the efficacy and safety of peginterferon plus ribavirin for chronic hepatitis C (CHC) patients under real life setting in Korea. METHODS: We retrospectively analyzed the medical records of 758 CHC patients treated with peginterferon plus ribavirin between 2000 and 2008 from 14 university hospitals in the Gyeonggi-Incheon area in Korea. RESULTS: Hepatitis C virus (HCV) genotype 1 was detected in 61.2% of patients, while genotype 2 was detected in 35.5%. Baseline HCV RNA level was > or =6x10(5) IU/mL in 51.6% of patients. The sustained virological response (SVR) rate was 59.6% regardless of genotype; 53.6% in genotype 1 and 71.4% in genotype 2/3. On multivariate analysis, male gender (p=0.011), early virological response (p<0.001), genotype 2/3 (p<0.001), HCV RNA <6x10(5) IU/mL (p=0.005) and adherence to the drug >80% of the planned dose (p<0.001) were associated with SVR. The rate of premature discontinuation was 35.7%. The main reason for withdrawal was intolerance to the drug due to common adverse events or cytopenia (48.2%). CONCLUSIONS: Our data suggest that the efficacy of peginterferon and ribavirin therapy in Koreans is better in Koreans than in Caucasians for the treatment of CHC, corroborating previous studies that have shown the superior therapeutic efficacy of this regimen in Asians.
Asian Continental Ancestry Group
;
Genotype
;
Hepacivirus
;
Hepatitis C, Chronic
;
Hepatitis, Chronic
;
Hospitals, University
;
Humans
;
Male
;
Medical Records
;
Multivariate Analysis
;
Retrospective Studies
;
Ribavirin
;
RNA
7.Flow Cytometry-Assisted Basophil Activation Test as a Safe Diagnostic Tool for Aspirin/NSAID Hypersenstivity.
Myung Shin KIM ; Young Joo CHO
Allergy, Asthma & Immunology Research 2012;4(3):137-142
PURPOSE: Aspirin and non-steroidal anti-inflammatory drugs (ASA/NSAIDs) are common causes of drug hypersensitivity. An oral provocation test is the only definitive diagnostic test. This study assessed the reliability of a flow cytometry-assisted basophil activation test (FAST) as a safe diagnostic method for ASA/NSAID-induced hypersensitivity, as its high sensitivity and specificity have been demonstrated for many other drugs. METHODS: Eighteen patients and 11 controls were enrolled. Using a Flow-CAST kit(R) (Buhlmann Laboratories AG, Schonenbuch, Switzerland), 29 analyses with aspirin, ibuprofen, and diclofenac were performed by flow cytometry to detect double-positive staining of anti-IgE and anti-CD63. The stimulation index was defined as the activated basophil percentage after drug stimulation/basally active basophil percentage. A stimulation index> or =2 and an absolute activated basophil percentage> or =5 were considered positive. RESULTS: Patients with hypersensitivity to ASA/NSAIDs were predominantly female, and the prevalence of atopy was higher in patients than in controls. A sensitivity of 61%, specificity of 91%, positive predictive value of 92%, and negative predictive value of 59% were achieved. CONCLUSIONS: FAST is a useful additional method for diagnosis of hypersensitivity reactions to ASA/NSAIDs. Further development is required to increase the sensitivity of the test.
Antibodies, Anti-Idiotypic
;
Aspirin
;
Basophils
;
Diagnostic Tests, Routine
;
Diclofenac
;
Drug Hypersensitivity
;
Female
;
Flow Cytometry
;
Humans
;
Hypersensitivity
;
Ibuprofen
;
Prevalence
8.Successful Primary Infliximab Treatment of Orofacial Crohn's Disease without Gastrointestinal Manifestation.
Bo Yong JUNG ; Suck Ho LEE ; Seung Kyu CHUNG ; Chang Kyun LEE ; Tae Hoon LEE ; Il Kwun CHUNG ; Sun Joo KIM ; Hyun Deuk CHO
The Korean Journal of Gastroenterology 2012;59(6):437-440
Crohn's disease is a chronic inflammatory bowel disease that can involve the whole gastrointestinal tract. The orofacial manifestation of Crohn's disease, which is rare, can develop irrespective of intestinal involvement. These orofacial lesions are often misdiagnosed as simple oral ulcers. Corticosteroids are the mainstay of therapy for orofacial Crohn's disease. However, infliximab, the chimeric monoclonal antibody to tumor necrosis factor-alpha, is now considered as a primary treatment because of the disease's relatively high rate of steroid resistance. We present a case of deep oral ulcer and periorbital swelling in a 65-year-old woman. She was diagnosed with intestinal Crohn's disease 7 years ago, which was in remission after treatment with an immunosuppressive agent (azathioprine). The patient was given the diagnosed with orofacial Crohn's disease and successfully treated with infliximab.
6-Mercaptopurine/analogs & derivatives/therapeutic use
;
Aged
;
Anti-Inflammatory Agents/*therapeutic use
;
Antibodies, Monoclonal/*therapeutic use
;
Crohn Disease/diagnosis/*drug therapy
;
Female
;
Gastrointestinal Diseases/pathology
;
Humans
;
Immunosuppressive Agents/therapeutic use
;
Oral Ulcer/diagnosis
9.Capsule Endoscopy for Suspected Small Bowel Bleeding in Patients with Portal Hypertension.
Gang Il CHEON ; Jin Oh KIM ; Sung Wook HONG ; Seong Ran JEON ; Tae Hee LEE ; Hyun Gun KIM ; Won Young CHO ; Wan Jung KIM ; Min Jeong KIM ; Sung Won JEONG ; Jae Young JANG ; Bong Min KO ; Joo Young CHO ; Joon Seong LEE
Intestinal Research 2011;9(2):129-138
BACKGROUND/AIMS: In Korea, limited data are available on small bowel bleeding in patients with portal hypertension. This study reports on the use of capsule endoscopy in cases of suspected small bowel bleeding in patients with portal hypertension. METHODS: Capsule endoscopy was used at our hospital to evaluate small bowel disease in 501 cases from July 2003 to June 2010. Of those cases, nine patients with portal hypertension due to liver cirrhosis with suspected small bowel bleeding were selected for the study. A retrospective analysis was performed using data from medical records. RESULTS: Six of the nine (66.7%) patients were males with an average age of 53.4 years. The average hemoglobin level was 8.1 g/dL. Abnormalities noted during capsule endoscopy included portal hypertensive enteropathy in all nine cases (100%), jejunal varices in four (44.4%), jejunal and ileal angiodysplasia in five (55.5%), multiple small bowel erosions in one (11.1%), granularity of the jejunal mucosa in one (11.1%), and small bowel erythema in three (33.3%). Active bleeding from jejunal varices was detected in two patients (22.2%). Despite having no obvious active bleeding during the capsule endoscopy, four patients (44.4%) were diagnosed with portal hypertensive enteropathy with obscure small bowel bleeding. CONCLUSIONS: Capsule endoscopy is a useful diagnostic tool for the evaluation of small bowel bleeding in patients with portal hypertensive enteropathy. Additional prospective and multicenter studies on the use of capsule endoscopy are needed to evaluate the incidence and clinical importance of portal hypertensive enteropathy.
Angiodysplasia
;
Capsule Endoscopy
;
Erythema
;
Hemoglobins
;
Hemorrhage
;
Humans
;
Hypertension, Portal
;
Incidence
;
Korea
;
Liver Cirrhosis
;
Male
;
Mucous Membrane
;
Retrospective Studies
;
Varicose Veins
10.A Case of Successful Endoscopic Treatment for Acute Recurrent Pancreatitis Due to Pancreas Divisum with Santorinicele Masquerading as Drug Induced Pancreatitis.
Yun Suk SHIM ; Tae Hoon LEE ; Jun Ho CHOI ; Sang Pil KIM ; Sae Hwan LEE ; Il Kwun CHUNG ; Sang Heum PARK ; Sun Joo KIM
Korean Journal of Gastrointestinal Endoscopy 2010;40(2):139-143
There are various causes of acute pancreatitis, and accurately determining the etiology is pivotal for selecting appropriate management. Other hidden causes, such as congenital anomaly, should be considered in patients with recurrent abdominal pain or unexplained recurrent pancreatitis. A santorinicele is a focal cystic dilatation of the terminal dorsal pancreatic duct, and this is usually associated with pancreas divisum and it is a risk factor for acute pancreatitis due to the accompanying relative stenosis of the minor papilla. We present here the case of a patient who was treated for acute pancreatitis that was presumably was caused by either Rifampin or Brucellosis, and the patient recovered with conservative management. However, we eventually diagnosed pancreas divisum with santorinicele by performing MRCP and ERCP after the pancreatitis had relapsed. We report here on a case of successful endoscopic treatment for pancreas divisum with santorinicele as a cause of recurrent pancreatitis, and this was initially confused with drug or infection related pancreatitis.
Abdominal Pain
;
Brucellosis
;
Cholangiopancreatography, Endoscopic Retrograde
;
Constriction, Pathologic
;
Dilatation
;
Humans
;
Pancreas
;
Pancreatic Ducts
;
Pancreatitis
;
Rifampin
;
Risk Factors

Result Analysis
Print
Save
E-mail